(Q46764291)

25 December 2017

title

Amphetamine-induced displacement of [18F] fallypride in striatum and extrastriatal regions in humans (English)

1 reference

25 December 2017

1 reference

5

1 reference

25 December 2017

Benoit Dawant

6

object named as

Benoit Dawant

1 reference

25 December 2017

author name string

Patrizia Riccardi

1

1 reference

25 December 2017

Rui Li

2

1 reference

25 December 2017

Mohammad Sib Ansari

3

1 reference

25 December 2017

David Zald

4

1 reference

25 December 2017

Sharlet Anderson

7

1 reference

25 December 2017

Mikisha Doop

8

1 reference

25 December 2017

Neil Woodward

9

1 reference

25 December 2017

Evan Schoenberg

10

1 reference

25 December 2017

Dennis Schmidt

11

1 reference

25 December 2017

Ronald Baldwin

12

1 reference

25 December 2017

Robert Kessler

13

1 reference

25 December 2017

language of work or name

English

0 references

publication date

1 May 2006

1 reference

25 December 2017

published in

Neuropsychopharmacology

1 reference

25 December 2017

volume

31

1 reference

25 December 2017

issue

5

1 reference

25 December 2017

page(s)

1016-1026

1 reference

25 December 2017

https://scigraph.springernature.com/pub.10.1038/sj.npp.1300916

exact match

0 references

cites work

Frontal and temporal dopamine release during working memory and attention tasks in healthy humans: a positron emission tomography study using the high-affinity dopamine D2 receptor ligand [11C]FLB 457.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300916

Alterations of benzodiazepine receptors in type II alcoholic subjects measured with SPECT and [123I]iomazenil.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300916

Dopamine mediation of positive reinforcing effects of amphetamine in stimulant naïve healthy volunteers: results from a large cohort

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300916

Striatal amphetamine-induced dopamine release in patients with schizotypal personality disorder studied with single photon emission computed tomography and [123I]iodobenzamide

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300916

Comparison of three high affinity SPECT radiotracers for the dopamine D2 receptor.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300916

Schizophrenia is associated with elevated amphetamine-induced synaptic dopamine concentrations: evidence from a novel positron emission tomography method

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300916

Optimizing limbic selective D2/D3 receptor occupancy by risperidone: a [123I]-epidepride SPET study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300916

Oral D-amphetamine causes prolonged displacement of [11C]raclopride as measured by PET.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300916

Measuring the in vivo binding parameters of [18F]-fallypride in monkeys using a PET multiple-injection protocol

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300916

Amphetamine-induced dopamine release in human ventral striatum correlates with euphoria.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300916

Assessment of dynamic neurotransmitter changes with bolus or infusion delivery of neuroreceptor ligands.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300916

Dendrodendritic inhibition through reversal of dopamine transport

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300916

A PET-study of [11C]FLB 457 binding to extrastriatal D2-dopamine receptors in healthy subjects and antipsychotic drug-treated patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300916

Improved Assessment of Significant Activation in Functional Magnetic Resonance Imaging (fMRI): Use of a Cluster‐Size Threshold

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300916

Dynamics of volume transmission in the brain. Focus on catecholamine and opioid peptide communication and the role of uncoupling protein 2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300916

Changes in somatodendritic but not terminal dopamine regulation in aged rhesus monkeys

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300916

Effect of reserpine-induced depletion of synaptic dopamine on [11C]raclopride binding to D2-dopamine receptors in the monkey brain.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300916

Personality traits and brain dopaminergic function in Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300916

Stability of [123I]IBZM SPECT measurement of amphetamine-induced striatal dopamine release in humans.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300916

A developmental perspective on the pathology and neurochemistry of the temporal lobe in schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300916

Visualization of extrastriatal dopamine D2 receptors in the human brain.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300916

High affinity dopamine D2 receptor radioligands. 3. [123I] and [125I]epidepride: in vivo studies in rhesus monkey brain and comparison with in vitro pharmacokinetics in rat brain.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300916

Identification of extrastriatal dopamine D2 receptors in post mortem human brain with [125I]epidepride.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300916

Drug addiction, dysregulation of reward, and allostasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300916

Comparison of methods for analysis of clinical [11C]raclopride studies.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300916

Imaging synaptic neurotransmission with in vivo binding competition techniques: a critical review

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300916

Single photon emission computerized tomography imaging of amphetamine-induced dopamine release in drug-free schizophrenic subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300916

Microdialysis and SPECT measurements of amphetamine-induced dopamine release in nonhuman primates.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300916

Phantom validation of coregistration of PET and CT for image-guided radiotherapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300916

The relationship between striatal dopamine receptor binding and cognitive performance in Huntington's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300916

Amphetamine-induced increases in extracellular dopamine, drug wanting, and novelty seeking: a PET/[11C]raclopride study in healthy men.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300916

Imaging human mesolimbic dopamine transmission with positron emission tomography: I. Accuracy and precision of D(2) receptor parameter measurements in ventral striatum

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300916

Systemic sulpiride in young adult volunteers simulates the profile of cognitive deficits in Parkinson's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300916

In vivo assessment of basal and drug-induced dopamine release in cortical and subcortical regions of the anesthetized primate

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300916

Brain imaging of 18F-fallypride in normal volunteers: blood analysis, distribution, test-retest studies, and preliminary assessment of sensitivity to aging effects on dopamine D-2/D-3 receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300916

Preliminary assessment of extrastriatal dopamine D-2 receptor binding in the rodent and nonhuman primate brains using the high affinity radioligand, 18F-fallypride

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300916

Fluorinated benzamide neuroleptics--III. Development of (S)-N-[(1-allyl-2-pyrrolidinyl)methyl]-5-(3-[18F]fluoropropyl)-2, 3-dimethoxybenzamide as an improved dopamine D-2 receptor tracer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300916

In vivo vulnerability to competition by endogenous dopamine: comparison of the D2 receptor agonist radiotracer (-)-N-[11C]propyl-norapomorphine ([11C]NPA) with the D2 receptor antagonist radiotracer [11C]-raclopride

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300916

Effect of endogenous dopamine on extrastriatal [¹¹C]FLB 457 binding measured by PET.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300916

Differentiation of extrastriatal dopamine D2 receptor density and affinity in the human brain using PET.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300916

Spatial working memory deficits and clinical symptoms in schizophrenia: a 4-month follow-up study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300916

Dopaminergic activity is reduced in the prefrontal cortex and increased in the nucleus accumbens of rats predisposed to develop amphetamine self-administration

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300916

Endogenous dopamine release after pharmacological challenges in Parkinson's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300916

Limbic selectivity of clozapine.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300916

Distribution of dopamine D2-like receptors in the human thalamus: autoradiographic and PET studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300916

The adaptive bases algorithm for intensity-based nonrigid image registration

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300916

D1 Dopamine Receptors in Prefrontal Cortex: Involvement in Working Memory

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300916

Clinical and psychometric correlates of dopamine D2 binding in depression.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300916

Elevated intrasynaptic dopamine release in Tourette's syndrome measured by PET.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300916

Effect of amphetamine on [(18)F]fallypride in vivo binding to D(2) receptors in striatal and extrastriatal regions of the primate brain: Single bolus and bolus plus constant infusion studies.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300916

Decreased dopamine D2 receptor binding in the anterior cingulate cortex in schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300916

No support for regional selectivity in clozapine-treated patients: a PET study with [(11)C]raclopride and [(11)C]FLB 457.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300916

Comparative effects of methamphetamine and nicotine on the striatal [(11)C]raclopride binding in unanesthetized monkeys

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300916

Isoflurane anesthesia enhances the inhibitory effects of cocaine and GBR12909 on dopamine transporter: PET studies in combination with microdialysis in the monkey brain.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300916

Dopamine in drug abuse and addiction: results from imaging studies and treatment implications

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300916

Imaging endogenous dopamine competition with [11C]raclopride in the human brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300916

Development and validation of brief measures of positive and negative affect: The PANAS scales

21 January 2018

2 references

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300916

21 January 2018

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300916

7 January 2021

Prefrontal neurons and the genetics of schizophrenia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300916

Comparison and evaluation of retrospective intermodality brain image registration techniques.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300916

The Structured Clinical Interview for DSM-III-R (SCID). II. Multisite test-retest reliability

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300916

In vivo extrastriatal and striatal D2 dopamine receptor blockade by amisulpride in schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300916

Extrastriatal and striatal D(2) dopamine receptor blockade with haloperidol or new antipsychotic drugs in patients with schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300916

Low dopamine d(2) receptor binding in subregions of the thalamus in schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300916

Immunocytochemical localization of D1 and D2 dopamine receptors in the basal ganglia of the rat: light and electron microscopy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300916

Amphetamine and methamphetamine determination in urine by reversed-phase high-performance liquid chromatography with simultaneous sample clean-up and derivatization with naphthoquinone 4-sulphonate on solid-phase cartridges

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300916

Early pharmacokinetics and clinical effects of oral D-amphetamine in normal subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300916

7 January 2021

Striatal and temporal cortical D2/D3 receptor occupancy by olanzapine and sertindole in vivo: a [123I]epidepride single photon emission tomography (SPET) study

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300916

7 January 2021

Effect of amphetamine on extrastriatal D2 dopamine receptor binding in the primate brain: a PET study

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300916

7 January 2021

Differential autoreceptor control of somatodendritic and axon terminal dopamine release in substantia nigra, ventral tegmental area, and striatum

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300916

7 January 2021

Dopamine-mediated volume transmission in midbrain is regulated by distinct extracellular geometry and uptake

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300916

7 January 2021

Different kinetics govern dopaminergic transmission in the amygdala, prefrontal cortex, and striatum: an in vivo voltammetric study.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300916

7 January 2021

The cortical dopamine system: role in memory and cognition

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300916

7 January 2021

Biochemistry of somatodendritic dopamine release in substantia nigra: an in vivo comparison with striatal dopamine release.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300916

7 January 2021

Individual locomotor response to novelty predicts selective alterations in D1 and D2 receptors and mRNAs.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300916

7 January 2021

High affinity dopamine D2 receptor radioligands. 2. [125I]epidepride, a potent and specific radioligand for the characterization of striatal and extrastriatal dopamine D2 receptors

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300916

7 January 2021

Evaluation of 5-[18F]fluoropropylepidepride as a potential PET radioligand for imaging dopamine D2 receptors

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300916

7 January 2021

Enhanced vulnerability to cocaine self-administration is associated with elevated impulse activity of midbrain dopamine neurons.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300916

7 January 2021

Quantification of [11C]FLB 457 binding to extrastriatal dopamine receptors in the human brain

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300916

7 January 2021

Ultrastructural localization of D2 receptor-like immunoreactivity in midbrain dopamine neurons and their striatal targets.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300916

7 January 2021

Is synaptic dopamine concentration the exclusive factor which alters the in vivo binding of [11C]raclopride?: PET studies combined with microdialysis in conscious monkeys

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300916

7 January 2021

Sensation seeking in England and America: Cross-cultural, age, and sex comparisons

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300916

7 January 2021

Identifiers

DOI

10.1038/SJ.NPP.1300916

1 reference

25 December 2017

Dimensions Publication ID

0 references

1 reference

25 December 2017